首站-论文投稿智能助手
典型文献
Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease
文献摘要:
Metabolic-associated fatty liver disease(MAFLD)is the most common metabolic disease with a global prevalence of 25%.While MAFLD is serious and incurable at the later stage,it can be controlled or reversed at the early stage of hepatosteatosis originating from unhealthy diets.Recent laboratory evidence implicates a critical role of the mammalian target of rapamycin(mTOR)-autophagy signaling pathway in the pathogenesis of MAFLD induced by a high-fructose diet mimicking the overconsumption of sugar in humans.This review discusses the possible molecular mechanisms of mTOR-autophagy-endoplasmic reticulum(ER)stress in MAFLD.Based on careful analysis of recent studies,we suggest possible new therapeutic concepts or targets that can be explored for the discovery of new anti-MAFLD drugs.
文献关键词:
作者姓名:
Ya-lin Wang;Xiu Zhou;Dong-li Li;Ji-ming Ye
作者机构:
Biotechnology and Health Sciences,Wuyi University,Jiangmen 529020,China ;Biotechnology and Health Sciences,Wuyi University,Jiangmen 529020,China;School of Health and Biomedical Sciences,RMIT University,Melbourne,VIC,Australia
引用格式:
[1]Ya-lin Wang;Xiu Zhou;Dong-li Li;Ji-ming Ye-.Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease)[J].中国药理学报(英文版),2022(01):10-14
A类:
hepatosteatosis,overconsumption
B类:
Role,mTOR,autophagy,ER,stress,pathway,high,fructose,induced,metabolic,associated,fatty,liver,disease,Metabolic,MAFLD,most,common,global,prevalence,While,serious,incurable,later,stage,can,be,controlled,reversed,early,originating,from,unhealthy,diets,Recent,laboratory,evidence,implicates,critical,role,mammalian,rapamycin,signaling,pathogenesis,by,mimicking,sugar,humans,This,review,discusses,possible,molecular,mechanisms,endoplasmic,reticulum,Based,careful,analysis,recent,studies,we,suggest,new,therapeutic,concepts,targets,that,explored,discovery,anti,drugs
AB值:
0.613019
相似文献
Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway
Yonghui Zhang;Haoyang Zhang;Jinage Mu;Meiyue Han;Zhihao Cao;Feng Dong;Tingting Wang;Lian Pan;Wujing Luo;Jiaxin Li;Huan Liu;Lishan Jin;Wenxuan Ding;Yong Wei;Xuesong Deng;Dan Liu;Xiuzhen He;Yi Pang;Xiao Mu;Zhongjun Wu;Dilong Chen-The First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China;The People's Hospital Affiliated to Chongqing Three Gorges Medical College,Chongqing 404100,China;Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area,Chongqing 404120,China;Chongqing Engineering Research Center of Antitumor Natural Drugs,Chongqing 404120,China;Key Laboratory of Intelligent Information Processing and Control,College of Electronic and Information Engineering,Chongqing Three Gorges University,Chongqing 404110,China
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria:a prospective cohort study
Jialu Wang;Shanshan Liu;Qiuyu Cao;Shujing Wu;Jingya Niu;Ruizhi Zheng;Lizhan Bie;Zhuojun Xin;Yuanyue Zhu;Shuangyuan Wang;Hong Lin;Tiange Wang;Min Xu;Jieli Lu;Yuhong Chen;Yiping Xu;Weiqing Wang;Guang Ning;Yu Xu;Mian Li;Yufang Bi;Zhiyun Zhao-Department of Endocrine and Metabolic Diseases,Shanghai Institute of Endocrine and Metabolic Diseases,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai National Clinical Research Center for Metabolic Diseases,Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China,Shanghai Key Laboratory for Endocrine Tumor,State Key Laboratory of Medical Genomics,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Clinical Trials Center,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。